Published in Medical Letter on the CDC and FDA, December 5th, 2010
"This regulatory milestone is an important step in our efforts to advance the care of patients with end-stage renal disease," said Carlos Alonso, president of Baxter's global Renal business.
"We are gratified to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.